Biocon Limited

BSE : 532523 | NSE : BIOCON

Industry : Pharmaceuticals | ISIN : INE376G01013 | FreeFloat : 40.00% | FnO : Yes | LotSize : 2300


Intellectual Capital (IC)8,008.85
Net Worth (NW)9,470.00
Intrinsic Worth (IW)17,478.85
Market Cap (MC)40,292.14
Economic Value Added-137.69
Discount Rate%
Liquidity Premium%
Knowledge Basis (IC/IW)45.82%
IC Gross Margin (EBITDA/IC)24.94%
IC Net Margin (NPT/IC)13.73%
Knowledge Turnover (Sales/IC)1.09
Market to Intrinsic Value (MC/IW)2.31

As OfIntrinsic ValueMarket Price
31 Mar 2022Rs. 145.58Rs. 335.60
26 May 2022 ---- Rs. 325.40
1.20     0.37%
Fundamental - medium termTechnical - near termCombined outlook
EVA > 0 : NoSell10 DMA : Rs. 329.39AccumulateSell on Rallies
KB > 50% : No50 DMA : Rs. 345.36
0 < M2IV < 1 : NoVol-Price trend : Rising

Question 3 - Is this stock undervalued?


Question 2 - Does this business have significant knowledge assets?


Question 1 - Is this business generating enough profits to cover its cost of capital?

* EVA is a registered trademark of Stern Stewart and Co.

Quarterly Results (Rs. Cr)
Quarter
Type*
Sales
Income
EBITDA
EBIT
PBT
PAT
NPT
Jun-19
C
1465.90
1490.00
453.70
329.50
312.90
227.70
206.30
Sep-19
C
1572.20
1610.60
509.30
377.70
353.90
215.70
206.80
Dec-19
C
1748.10
1783.90
476.80
332.80
315.10
202.80
235.50
Mar-20
C
1581.00
1644.10
373.30
220.90
204.10
123.40
72.10
Jun-20
C
1671.30
1689.60
431.60
264.80
252.30
167.80
137.00
Sep-20
C
1744.80
1760.30
406.90
229.20
222.70
195.40
276.60
Dec-20
C
1851.00
1878.90
427.40
241.10
236.30
186.60
189.89
Mar-21
C
1838.70
2044.10
584.30
400.00
366.10
296.40
358.30
Jun-21
C
1760.60
1807.80
380.40
185.60
165.70
108.40
102.40
Sep-21
C
1840.40
1945.30
430.00
228.50
206.00
159.70
224.80
Dec-21
C
2174.20
2222.50
489.30
283.60
268.90
219.60
270.60
Mar-22
C
2408.80
2476.10
606.20
394.00
383.50
283.90
339.80
* C - Consolidated, S - Standalone